Treatment Information

Back

Liver Cancer treatment details. Chemotherapy, Biologic therapy.

National Taiwan University Hospital, Taipei, Taiwan Region.

Survival: monthsCountry:Taiwan Region
Toxiciy Grade:4City/State/Province:Taipei
Treatments:Chemotherapy, Biologic therapyHospital:National Taiwan University Hospital
Drugs:Journal:Link
Date:Jul 2010

Description:

Patients:
This phase II study involved 53 patients with advanced hepatocellular carcinoma. The median patient age was 57 years and 89% were male.

Treatment:
Patients were treated with the biologic therapy agent sorafenib (blocks cancer cell growth by targeting tyrosine kinase proteins on the cell surface) and the chemotherapy agent tegafur/uracil.

Toxicities:
The most severe toxicities were grade 4 elevation of the lipase enzyme. Grade 3 fatigue, hand-foot skin reaction, and bleeding were also reported.

Results:
The median progression-free survival was 3.7 months and the median overall survival was 7.4 months.

Support:
This study was partially supported by the pharmaceutical company Bayer HealthCare.

Correspondence: Dr. Chiun Hsu; email: [email protected]



Back